About Mapaex Remedies Private Limited
Data last updated:
Mapaex Remedies Private Limited was a private limited company based in Wadhwan, Gujarat, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 April 2005.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U02423GJ2005PTC094538. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Rajendra Chandrakant Patel (Managing Director) and Kalpesh Dhanjibhai Makasana.
Its last annual general meeting (AGM) was held on 25 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Tapovan Nearpatelboarding60Feetroad, Wadhwan, Gujarat, India – 363030.
As per the financials filed for FY 2017, the company reported a revenue of ₹22.57 Cr, a decline of 52% compared to the previous year. For the same year it recorded a net profit of ₹14.51 Cr (net margin 64.3%) and EBITDA of ₹19.17 Cr (EBITDA margin 84.9%).
The last known website on record is maksongroup.com.
Company details
CIN history
Mapaex Remedies has one previous CIN (Corporate Identification Number): U02423MP2005PTC017508. The current CIN is U02423GJ2005PTC094538, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U02423GJ2005PTC094538 | Current |
| U02423MP2005PTC017508 | Previous |
Contact details
Mapaex Remedies Private Limited's registered office is in Wadhwan, Gujarat. Its website is maksongroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressTapovan Nearpatelboarding60Feetroad, Wadhwan, Gujarat, India – 363030
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mapaex Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mapaex Remedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mapaex Remedies Private Limited, buy the company report.
Financials of Mapaex Remedies Private Limited
FY 2017 filings availableMapaex Remedies Private Limited reported revenue of ₹22.57 Cr (down 52% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue fell 52% in the latest year. EBITDA fell 26% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹22.57 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹19.17 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹14.51 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 84.9% | ||
| Net Profit Margin | 64.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Mapaex Remedies Private Limited, buy the company report.
Board of directors of Mapaex Remedies Private Limited
Mapaex Remedies has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Chandrakant Patel Also directs: Makson Vitrified LLP, Makson Healthcare Private Limited, Mapaex Health and Personalcare Private Limited and 5 more | Managing Director | 23 Dec 2015 | 10 Years 10 Months | As last reported |
| Kalpesh Dhanjibhai Makasana | Director | 12 Apr 2006 | 20 Years 7 Months | As last reported |
| Mayur Chandrakant Patel Also directs: Makson Vitrified LLP, Makson Healthcare Private Limited, Mapaex Health and Personalcare Private Limited and 5 more | Director | 23 Dec 2015 | 10 Years 10 Months | As last reported |
Peer comparison
Mapaex Remedies Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr. Smiths Biotech Private Limited | ₹22.7 Cr (FY 2023) | 40.0% | Pune, Maharashtra, India | |||
| Astamed Healthcare ( India ) Private Limited | ₹22.66 Cr (FY 2025) | -10.0% | Mumbai, Maharashtra, India | |||
| Disto Pharmaceuticals Private Limited | ₹22.63 Cr (FY 2024) | -5.0% | Hyderabad, Telangana, India | |||
| Mapaex Remedies Private Limitedthis company | ₹22.57 Cr (FY 2017) | ₹14.51 Cr | 64.3% | -52.0% | Wadhwan, Gujarat, India | |
| Athulitha Laboratories Private Limited | ₹22.56 Cr (FY 2024) | 66.0% | Hyderabad, Telangana, India | |||
| Beryl Drugs Limited | ₹22.55 Cr (FY 2025) | -17.0% | Indore, Madhya Pradesh, India | |||
| Sherrington Pharmaceuticals Private Limited | ₹22.55 Cr (FY 2024) | 3.0% | Hyderabad, Telangana, India | |||
| Ancalima Lifesciences Limited | ₹22.53 Cr (FY 2024) | 4.0% | Sonipat, Haryana, India |
To see the full peer comparison of Mapaex Remedies Private Limited, buy the company report.
Auditor
Mapaex Remedies Private Limited is audited by BANSAL & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BANSAL & CO. | FY 2017 | 01113N |
Shareholding
The shareholding of Mapaex Remedies Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mapaex Remedies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mapaex Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mapaex Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mapaex Remedies has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Mapaex Remedies Private Limited, buy the company report.
Recent activity
Mapaex Remedies Private Limited has 6 board changes on record since 2006: 3 appointments and 3 cessations. The latest: Chhaya Mayur Patel ceased to be Director on 24 Dec 2015.
Frequently asked questions
Mapaex Remedies has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Mapaex Remedies was a private limited company based in Wadhwan, Gujarat, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 12 April 2005 and is registered under CIN U02423GJ2005PTC094538. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Mapaex Remedies was incorporated on 12 April 2005. It is registered with the Registrar of Companies, Ahmedabad.
Mapaex Remedies had 3 directors:
- Rajendra Chandrakant Patel - Managing Director
- Kalpesh Dhanjibhai Makasana - Director
- Mayur Chandrakant Patel - Director
The CIN (Corporate Identification Number) of Mapaex Remedies is U02423GJ2005PTC094538. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Mapaex Remedies is at Tapovan Nearpatelboarding60Feetroad, Wadhwan, Gujarat, India – 363030.
Mapaex Remedies can be reached through the website maksongroup.com. Its registered office is in Wadhwan, Gujarat, India.
The latest financial statements of Mapaex Remedies on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 25 September 2017. Year-wise statements from 2015 are in the company report.
No. Mapaex Remedies has 2 GST registrations on record and all of them are cancelled or inactive.
Mapaex Remedies operated in the pharma industry, in the drug formulation and development segment.
The peers of Mapaex Remedies by revenue are Dr. Smiths Biotech Private Limited, Astamed Healthcare ( India ) Private Limited, Disto Pharmaceuticals Private Limited, Athulitha Laboratories Private Limited, Beryl Drugs Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
